ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Bain Capital Life Sciences Investors, LLC bought $5.0M of Arcutis Biotherapeutics, Inc.
10% owner
Bought$4,999,989
$17.00Price
294,117Shares
+8%Stake
What ARQT did for a copier
Prices for ARQT after this filing aren't in yet.
Bain Capital Life Sciences Investors, LLC's record
4 other buys with 3 months of prices since 2017: on average −38.3% against the S&P 500, and 0 of 4 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Feb 4. Filed Thu, Feb 6, 4:26 PM ET, after the close. Not investment advice.